1,2-dimethylhydrazine multiple interactions ISO RGD:733573 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of CXADR mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:733573 6480464 1, 2-Dimethylhydrazine results in decreased expression of CXADR mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CXADR mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CXADR mRNA CTD PMID:17557909 17beta-estradiol increases expression ISO RGD:1346916 6480464 Estradiol results in increased expression of CXADR mRNA more ... CTD PMID:18618240 17beta-estradiol multiple interactions ISO RGD:1346916 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CXADR mRNA CTD PMID:30165855 17beta-estradiol affects expression ISO RGD:1346916 6480464 Estradiol affects the expression of CXADR mRNA CTD PMID:14699072 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1346916 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXADR mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXADR mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733573 6480464 Tetrachlorodibenzodioxin affects the expression of CXADR mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXADR mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CXADR mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733573 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXADR mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CXADR promoter] CTD PMID:19654925 , PMID:25975270 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CXADR mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1346916 6480464 Lactic Acid results in decreased expression of CXADR mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CXADR mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide increases expression ISO RGD:733573 6480464 Fenretinide results in increased expression of CXADR mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1346916 6480464 Decitabine promotes the reaction [trichostatin A results in increased expression of CXADR mRNA alternative form], Decitabine promotes the reaction [trichostatin A results in increased expression of CXADR mRNA] CTD PMID:18618240 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CXADR mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of CXADR mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:733573 6480464 Aflatoxin B1 results in decreased expression of CXADR mRNA CTD PMID:19770486 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CXADR mRNA CTD PMID:16483693 arsane affects methylation ISO RGD:1346916 6480464 Arsenic affects the methylation of CXADR gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1346916 6480464 Arsenic affects the methylation of CXADR gene CTD PMID:25304211 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CXADR mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO RGD:1346916 6480464 Benzo(a)pyrene results in increased methylation of CXADR 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1346916 6480464 Benzo(a)pyrene results in decreased expression of CXADR mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene decreases expression ISO RGD:733573 6480464 Benzo(a)pyrene results in decreased expression of CXADR mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1346916 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1346916 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CXADR mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:733573 6480464 bisphenol A results in increased expression of CXADR mRNA CTD PMID:25594700 bosentan decreases expression ISO RGD:1346916 6480464 bosentan results in decreased expression of CXADR mRNA, bosentan results in decreased expression of CXADR protein CTD PMID:20392896 bosentan multiple interactions ISO RGD:1346916 6480464 EDN1 protein inhibits the reaction [bosentan results in decreased expression of CXADR mRNA] CTD PMID:20392896 butanal increases expression ISO RGD:1346916 6480464 butyraldehyde results in increased expression of CXADR mRNA CTD PMID:26079696 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of CXADR promoter CTD PMID:22457795 calcitriol multiple interactions ISO RGD:1346916 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CXADR mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1346916 6480464 Calcitriol results in increased expression of CXADR mRNA CTD PMID:16002434 , PMID:21592394 choline multiple interactions ISO RGD:733573 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CXADR gene CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:733573 6480464 Ciguatoxins affects the expression of CXADR mRNA CTD PMID:18353800 clofibrate decreases expression ISO RGD:733573 6480464 Clofibrate results in decreased expression of CXADR mRNA CTD PMID:17585979 clothianidin increases expression ISO RGD:1346916 6480464 clothianidin results in increased expression of CXADR mRNA CTD PMID:29044138 copper atom multiple interactions ISO RGD:733573 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CXADR mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:733573 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CXADR mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1346916 6480464 Copper Sulfate results in decreased expression of CXADR mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1346916 6480464 Asbestos, Crocidolite results in increased expression of CXADR mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO RGD:733573 6480464 Cyclosporine results in decreased expression of CXADR mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1346916 6480464 Cyclosporine results in decreased expression of CXADR mRNA CTD PMID:20106945 more ... dextran sulfate multiple interactions ISO RGD:733573 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CXADR mRNA CTD PMID:29950665 dibutyl phthalate increases expression ISO RGD:733573 6480464 Dibutyl Phthalate results in increased expression of CXADR mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1346916 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CXADR mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1346916 6480464 Doxorubicin results in increased expression of CXADR mRNA CTD PMID:29803840 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of CXADR mRNA CTD PMID:27163883 folic acid multiple interactions ISO RGD:733573 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CXADR gene more ... CTD PMID:20938992 , PMID:22206623 genistein decreases expression ISO RGD:733573 6480464 Genistein results in decreased expression of CXADR mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CXADR mRNA CTD PMID:22061828 L-methionine multiple interactions ISO RGD:733573 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CXADR gene CTD PMID:20938992 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CXADR mRNA CTD PMID:30467583 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of CXADR mRNA CTD PMID:25972201 mitoxantrone affects response to substance ISO RGD:1346916 6480464 CXADR protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-methylformamide affects expression ISO RGD:733573 6480464 methylformamide affects the expression of CXADR mRNA, methylformamide analog affects the expression of CXADR mRNA CTD PMID:17040096 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CXADR mRNA CTD PMID:19638242 N-nitrosodiethylamine increases expression ISO RGD:733573 6480464 Diethylnitrosamine results in increased expression of CXADR mRNA CTD PMID:24535843 nickel dichloride decreases expression ISO RGD:1346916 6480464 nickel chloride results in decreased expression of CXADR mRNA CTD PMID:17312168 nickel sulfate decreases expression ISO RGD:1346916 6480464 nickel sulfate results in decreased expression of CXADR mRNA CTD PMID:22714537 paracetamol affects expression ISO RGD:733573 6480464 Acetaminophen affects the expression of CXADR mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1346916 6480464 Acetaminophen results in decreased expression of CXADR mRNA CTD PMID:29067470 pirinixic acid multiple interactions ISO RGD:733573 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CXADR mRNA CTD PMID:19710929 potassium iodide decreases expression EXP 6480464 Potassium Iodide results in decreased expression of CXADR mRNA CTD PMID:32593569 propiconazole increases expression ISO RGD:733573 6480464 propiconazole results in increased expression of CXADR mRNA CTD PMID:21278054 rac-lactic acid decreases expression ISO RGD:1346916 6480464 Lactic Acid results in decreased expression of CXADR mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:1346916 6480464 Raloxifene Hydrochloride affects the expression of CXADR mRNA CTD PMID:14699072 SB 431542 increases expression ISO RGD:1346916 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of CXADR protein CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:1346916 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CXADR mRNA CTD PMID:27188386 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of CXADR mRNA CTD PMID:25993096 sunitinib decreases expression ISO RGD:1346916 6480464 Sunitinib results in decreased expression of CXADR mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:1346916 6480464 Tamoxifen results in increased expression of CXADR mRNA more ... CTD PMID:18618240 tert-butyl hydroperoxide decreases expression ISO RGD:1346916 6480464 tert-Butylhydroperoxide results in decreased expression of CXADR mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1346916 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CXADR mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1346916 6480464 Testosterone results in increased expression of CXADR mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:733573 6480464 Carbon Tetrachloride results in increased expression of CXADR mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide affects expression ISO RGD:733573 6480464 titanium dioxide affects the expression of CXADR mRNA CTD PMID:27760801 titanium dioxide multiple interactions ISO RGD:733573 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CXADR mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:733573 6480464 titanium dioxide results in increased expression of CXADR mRNA CTD PMID:19464567 , PMID:23557971 torcetrapib increases expression ISO RGD:1346916 6480464 torcetrapib results in increased expression of CXADR mRNA CTD PMID:23228038 trichostatin A multiple interactions ISO RGD:1346916 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:18618240 , PMID:27188386 trichostatin A decreases expression ISO RGD:1346916 6480464 trichostatin A results in decreased expression of CXADR mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A increases expression ISO RGD:1346916 6480464 trichostatin A results in increased expression of CXADR mRNA, trichostatin A results in increased expression of CXADR mRNA alternative form CTD PMID:18618240 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CXADR mRNA CTD PMID:30589522 valproic acid affects expression ISO RGD:733573 6480464 Valproic Acid affects the expression of CXADR mRNA CTD PMID:17292431 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of CXADR mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:1346916 6480464 Valproic Acid results in increased expression of CXADR mRNA CTD PMID:23179753 more ... valsartan decreases expression ISO RGD:1346916 6480464 Valsartan results in decreased expression of CXADR mRNA, Valsartan results in decreased expression of CXADR protein CTD PMID:20392896 vancomycin decreases expression ISO RGD:733573 6480464 Vancomycin results in decreased expression of CXADR mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CXADR mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1346916 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CXADR mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1346916 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CXADR mRNA CTD PMID:18593933
Biological Process actin cytoskeleton reorganization ISO RGD:1346916 1624291 (PMID:17675666) RGD PMID:17675666 actin cytoskeleton reorganization ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 AV node cell to bundle of His cell communication ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 AV node cell to bundle of His cell communication ISO RGD:733573 1624291 (MGI:3814765, PMID:18636119) RGD MGI:3814765 , PMID:18636119 AV node cell-bundle of His cell adhesion involved in cell communication ISO RGD:733573 1624291 (MGI:3814765, PMID:18636119) RGD MGI:3814765 , PMID:18636119 cardiac muscle fiber development ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cardiac muscle fiber development ISO RGD:733573 1624291 MGI:3587803 (MGI:3587448 , PMID:16079292) RGD MGI:3587448 , PMID:16079292 cell-cell adhesion ISO RGD:733573 1624291 (MGI:5294315, PMID:10814828) RGD MGI:5294315 , PMID:10814828 cell-cell junction organization ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell-cell junction organization ISO RGD:733573 1624291 MGI:3711226 (MGI:3709954 , PMID:16543498) RGD MGI:3709954 , PMID:16543498 defense response to virus ISO RGD:1346916 1624291 (PMID:14978041) RGD PMID:14978041 epithelial structure maintenance ISO RGD:1346916 1624291 (PMID:15304526) RGD PMID:15304526 epithelial structure maintenance ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 gamma-delta T cell activation ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 gamma-delta T cell activation ISO RGD:733573 1624291 (MGI:4822257, PMID:20813954) RGD MGI:4822257 , PMID:20813954 germ cell migration ISO RGD:733573 1624291 (PMID:17690169) RGD PMID:17690169 germ cell migration ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 heart development ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 heart development ISO RGD:733573 1624291 MGI:3583765 more ... RGD MGI:3583046 more ... heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules ISO RGD:1346916 1624291 (PMID:12869515), (PMID:15800062) RGD PMID:12869515 , PMID:15800062 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 homotypic cell-cell adhesion ISO RGD:1346916 1624291 (PMID:11734628) RGD PMID:11734628 homotypic cell-cell adhesion ISS UniProtKB:P78310-1 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrion organization ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrion organization ISO RGD:733573 1624291 MGI:3587803 (MGI:3587448 , PMID:16079292) RGD MGI:3587448 , PMID:16079292 negative regulation of cardiac muscle cell proliferation ISO RGD:733573 1624291 MGI:3711226 (MGI:3709954 , PMID:16543498) RGD MGI:3709954 , PMID:16543498 neutrophil chemotaxis ISO RGD:1346916 1624291 (PMID:15800062) RGD PMID:15800062 neutrophil chemotaxis ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of AV node cell action potential ISO RGD:733573 1624291 (MGI:3814765, PMID:18636119) RGD MGI:3814765 , PMID:18636119 transepithelial transport ISO RGD:1346916 1624291 (PMID:15800062) RGD PMID:15800062 Cellular Component acrosomal vesicle ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 acrosomal vesicle ISO RGD:733573 1624291 (MGI:3622496, PMID:16410001) RGD MGI:3622496 , PMID:16410001 adherens junction ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 adherens junction ISO RGD:1346916 1624291 (PMID:12297051), (PMID:25468996) RGD PMID:12297051 , PMID:25468996 apicolateral plasma membrane ISO RGD:1346916 1624291 (PMID:15364909) RGD PMID:15364909 apicolateral plasma membrane ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 basolateral plasma membrane ISO RGD:1346916 1624291 (PMID:11316797), (PMID:20361046) RGD PMID:11316797 , PMID:20361046 basolateral plasma membrane ISO RGD:733573 1624291 (MGI:5294314, PMID:11316797) RGD MGI:5294314 , PMID:11316797 bicellular tight junction IDA 1299248 RGD bicellular tight junction ISO RGD:733573 1624291 (MGI:4948795 more ... RGD MGI:4948795 more ... bicellular tight junction ISO RGD:1346916 1624291 (PMID:11734628), (PMID:15800062), (PMID:22003382) RGD PMID:11734628 more ... bicellular tight junction IDA 8553448 PMID:17675666 UniProt cell body ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell body ISO RGD:733573 1624291 (MGI:5294315, PMID:10814828) RGD MGI:5294315 , PMID:10814828 cell junction ISO RGD:1346916 1624291 RGD GO_REF:0000052 cell-cell junction ISO RGD:1346916 1624291 (PMID:17675666), (PMID:20235596) RGD PMID:17675666 , PMID:20235596 cell-cell junction ISO RGD:733573 1624291 (MGI:3624600, PMID:16678988) RGD MGI:3624600 , PMID:16678988 cytoplasm ISO RGD:1346916 1624291 (PMID:22003382) RGD PMID:22003382 cytoplasm ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 extracellular space ISO RGD:1346916 1624291 (PMID:14978041) RGD PMID:14978041 filopodium ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 filopodium ISO RGD:733573 1624291 (MGI:5294315, PMID:10814828) RGD MGI:5294315 , PMID:10814828 growth cone ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 growth cone ISO RGD:733573 1624291 (MGI:5294315, PMID:10814828) RGD MGI:5294315 , PMID:10814828 integral component of membrane IEA UniProtKB-KW:KW-0812 1600115 GO_REF:0000043 UniProt GO_REF:0000043 intercalated disc ISO RGD:1346916 1624291 (PMID:15533241) RGD PMID:15533241 intercalated disc ISO RGD:733573 1624291 (MGI:3814765, PMID:18636119) RGD MGI:3814765 , PMID:18636119 membrane raft ISO RGD:1346916 1624291 (PMID:17675666) RGD PMID:17675666 membrane raft ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 neuromuscular junction ISO RGD:1346916 1624291 (PMID:15533241) RGD PMID:15533241 neuron projection IDA 8554646 PMID:19461877 UniProt neuron projection ISO RGD:733573 1624291 (MGI:5294315, PMID:10814828) RGD MGI:5294315 , PMID:10814828 nucleoplasm ISO RGD:1346916 1624291 RGD GO_REF:0000052 nucleoplasm IEA UniProtKB:P78310 , ensembl:ENSP000002848781600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleus ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 plasma membrane ISO RGD:1346916 1624291 (PMID:9096397) RGD GO_REF:0000052, PMID:9096397 plasma membrane ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein-containing complex ISO RGD:1346916 1624291 (PMID:17675666) RGD PMID:17675666 Molecular Function beta-catenin binding ISO RGD:1346916 1624291 UniProtKB:P35222 (PMID:12297051) RGD PMID:12297051 beta-catenin binding ISO RGD:733573 1624291 UniProtKB:Q02248 (MGI:3814765 , PMID:18636119) RGD MGI:3814765 , PMID:18636119 beta-catenin binding ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell adhesion molecule binding ISO RGD:1346916 1624291 UniProtKB:Q86YT9 (PMID:12869515), (PMID:15800062) RGD PMID:12869515 , PMID:15800062 cell adhesion molecule binding ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 connexin binding ISS UniProtKB:P97792 1600115 GO_REF:0000024 UniProt GO_REF:0000024 connexin binding ISO RGD:733573 1624291 UniProtKB:P28229 (MGI:3814765 , PMID:18636119) RGD MGI:3814765 , PMID:18636119 identical protein binding ISO RGD:1346916 1624291 (PMID:14978041) RGD PMID:14978041 integrin binding ISO RGD:1346916 1624291 UniProtKB:P13612 (PMID:12869515) RGD PMID:12869515 PDZ domain binding ISO RGD:1346916 1624291 UniProtKB:O75970 (PMID:15364909) RGD PMID:15364909 PDZ domain binding ISS UniProtKB:P78310 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein binding ISO RGD:1346916 1624291 UniProtKB:P21145 more ... RGD PMID:11734628 more ... protein binding ISO RGD:733573 1624291 PR:O70263 more ... RGD MGI:3590024 more ... signaling receptor binding ISO RGD:1346916 1624291 UniProtKB:P78310-1 more ... RGD PMID:14978041
Gene-Chemical Interaction Annotations
